AI-Designed Drugs Can Now Target Previously ‘Undruggable’ Proteins in Cancer and Alzheimer’s
A new AI tool from Nobel laureate David Baker opens the door for designer drugs that tackle pain, cancer, and brain diseases.| SingularityHub
A new AI tool from Nobel laureate David Baker opens the door for designer drugs that tackle pain, cancer, and brain diseases.| SingularityHub
Phase 3 clinical studies in people with melanoma and a type of lung cancer are underway, with earlier stage clinical trials for other cancers in the works.| SingularityHub
